Lack Of Progress On Drug Resistance Since AMR Review, New Report Says

The Telegraph: ‘Startling’ lack of progress in fight against superbugs, report warns
“Governments and pharmaceutical companies have made a ‘startling’ lack of progress in tackling superbugs, more than three years since a landmark report warned of their growing threat. … [A] report tracking progress since the 2016 review, has found that little has been done to tackle antimicrobial resistance (AMR), which is predicted to kill 10 million people by 2050 if it continues at its current rate…” (Gulland, 10/8).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.